Avalo Therapeutics Inc (AVTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
Sales | 181 | 322 | 651 | 0 | 0 |
Gross Profit | 181 | 322 | 651 | N/A | N/A |
Operating Expenses | 1,867 | 6,285 | 4,139 | 4,942 | 3,676 |
Operating Income | -1,686 | -5,963 | -3,488 | -4,942 | -3,676 |
Other Income | 48 | -205 | -36 | -198 | 27 |
Pre-tax Income | -1,639 | -6,169 | -3,524 | -5,140 | -3,649 |
Net Income Continuous | -1,639 | -6,169 | -3,524 | -5,140 | -3,649 |
Net Income | $-1,639 | $-6,169 | $-3,524 | $-5,140 | $-3,649 |
EPS Basic Total Ops | -485.91 | -2,000.80 | -1,171.90 | -1,686.39 | 16,606.64 |
EPS Basic Continuous Ops | -455.11 | -2,013.61 | -1,164.50 | -1,698.43 | 16,628.04 |
EPS Diluted Total Ops | -485.91 | -2,000.80 | -1,171.90 | -1,686.39 | 16,606.64 |
EPS Diluted Continuous Ops | -455.11 | -2,013.61 | -1,164.50 | -1,698.43 | 16,628.04 |
EBITDA(a) | $-1,680 | $-5,956 | $-3,481 | $-4,936 | $-3,669 |